PYRIDIN[3,4-B]PYRAZINONES

PYRIDIN[3,4-B]PYRAZINONES

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R2, R6A, R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BROWN, DAVID, LOUIS, FOBIAN, YVETTE, MARLENE, MOLYNEAUX, JOHN, MAJOR, PHILLIPS, CHRISTOPHER, JACOBSEN, ERIC, JON, MISCHKE, BRENT, VIRGIL, MADDUX, TODD, MICHAEL, ROGIER, DONALD, JOSEPH, JR, MOON, JOSEPH, BLAIR, TOLLEFSON, MICHAEL, BRENT, BROWN, DAVID, GRAHAM, FRESKOS, JOHN, NICHOLAS, PALMER, MICHAEL, JOHN, HEASLEY, STEVEN, EDWARD, WALKER, JOHN, KEITH, BELL, ANDREW, SIMON, HUGHES, ROBERT, O, OWEN, DAFYDD, RHYS
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R2, R6A, R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.